12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks experienced significant movements. Assure Holdings (IONM) and Shuttle Pharmaceuticals (SHPH) were among the gainers, with stocks rising 13.3% and 10.24%, respectively. Coherus BioSciences (CHRS) and Vicarious Surgical (RBOT) also saw their shares increase. On the losing side, Esperion Therapeutics (ESPR) and CNS Pharma (CNSP) experienced declines in their stock prices by 16.8% and 6.18%, respectively. Other losers included Alaunos Therapeutics (TCRT), Windtree Therapeutics (WINT), Jaguar Health (JAGX), and Ainos (AIMD).
January 18, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Coherus BioSciences' shares rose 9.58% to $2.63, with a market cap of $292.8 million.
The rise in Coherus BioSciences' stock price may continue into the short term, reflecting positive market sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Assure Holdings' stock rose by 13.3% to $0.31, with a market cap of $2.0 million.
The significant after-market rise in stock price suggests positive investor sentiment or reaction to company-specific news, which could lead to a short-term upward trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Vicarious Surgical's shares increased by 6.27% to $0.44, with a market cap of $77.5 million.
The after-market increase for Vicarious Surgical may suggest a positive short-term trajectory for the stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Shuttle Pharmaceuticals' stock increased by 10.24% to $0.49, with a market cap of $7.8 million.
The double-digit percentage increase in after-market hours could indicate a bullish short-term outlook for Shuttle Pharmaceuticals.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
CNS Pharma's shares decreased by 6.18% to $0.65, with a market cap of $4.0 million.
The decline in CNS Pharma's stock price in after-market trading could suggest bearish sentiment, possibly affecting the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Esperion Therapeutics' stock declined by 16.8% to $1.79, with a market cap of $203.5 million.
The significant drop in Esperion Therapeutics' stock price could indicate negative investor sentiment, potentially leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90